| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AHF ELISA Kit; Antihemophilic factor ELISA Kit; Coagulation factor VIII ELISA Kit; coagulation factor VIII; procoagulant component ELISA Kit; coagulation factor VIIIc ELISA Kit; DXS1253E ELISA Kit; F8 ELISA Kit; F8b ELISA Kit; F8c ELISA Kit; FA8_HUMAN ELISA Kit; factor VIII F8B ELISA Kit; Factor VIIIa light chain ELISA Kit; FactorVIII ELISA Kit; FVIII ELISA Kit; Hema ELISA Kit; Hemophilia A ELISA Kit; Hemophilia; classic ELISA Kit; OTTHUMP00000061446 ELISA Kit; OTTHUMP00000196174 ELISA Kit; Procoagulant component ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
coagulation factor VIII (FVⅢ) (F8) is a biological molecule commonly studied in immunology research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P00451
Biological context
Researchers often monitor coagulation factor VIII (FVⅢ) in serum, plasma, and tissue homogenates to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in coagulation factor VIII (FVⅢ) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, coagulation factor VIII (FVⅢ) may also appear under names such as AHF and Antihemophilic factor. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that coagulation factor VIII (FVⅢ) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion
N Jiang,Experimental Cell Research,2020
Urease immobilized GO core@shell heparin-mimicking polymer beads with safe and effective urea removal for blood purification
Zhang J, et al,International Journal of Biological Macromolecules,2019
Effect of the Novel Biodegradable N, O-Carboxymethylchitosan and Oligo-Chitosan on the Platelet Thrombogenicity Cascade in von Willebrand Disease
Periayah MH. et al,Thromb Res,2015
The Anticoagulant Effect of PGI2S and tPA in Transgenic Umbilical Vein Endothelial Cells Is Linked to Up-Regulation of PKA and PKC
Wang JH et al,Int J Mol Sci,2014